CompleGen is an early-stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.
CompleGen is an early-stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.Their system is used to build compound discovery systems for a broad range of therapeutic targets for the pharmaceutical industry, as well as efficient cost-effective product discovery systems for the agricultural industry.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 15, 2002 | Grant | $100K | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |